Clinical Trial Update: Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

This document reports Phase 2 results assessing rituximab's impact on MRI-detected disease activity in adults with moderate to severe rheumatoid arthritis; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Gaylis, Norman B., M.D. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED